Research & Development

夜射猫精品在线av啪啪网啪啪啪英媒:强生公司因阿片类药物案被罚5.7亿美元

發布時間︰

  仔細觀察了良久,雲瑯才確定,這座城池的原身應該是一片佔地極為廣闊的松林才對。   雲瑯有些絕望。夜射猫精品在线av   馬老六搖搖頭,這個時候再告訴幕煙皇帝來了,不但不會幫到他,甚至會是害了他。啪啪网   赫爾度奇怪的看著右賢王道︰“我們還沒有開始戰斗呢,大王怎麼說這樣的喪氣話。”啪啪啪   雲瑯當然不會認為自己有這種人見人愛的特質,他如今站在河邊上,瞅著咆哮的大河一頭栽進壺口。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo